Gentherm Reports 2013 First Quarter Results
President and CEO
"We also remain focused on developing new thermal management products for the automotive market, as well as applying our thermoelectric technology to applications in other markets including medical and batteries," Coker added. "We believe our technologies have a large number of potential commercial uses, and we are committed to exploring new initiatives in high-growth markets that will broaden our commercial product base, and generate future incremental revenue opportunities."
Revenues for the 2013 first quarter increased 14 percent to
Higher CCS revenue was primarily due to new program launches, including the newly designed Land Rover Range Rover, Infiniti JX and Nissan Pathfinder. Production volumes on existing vehicle platforms were higher in
W.E.T. revenue increases resulted from strong automotive volumes in
For this year's first quarter, foreign currency translation of the Company's Euro denominated revenue, which was approximately €34.9 million compared with €33.1 million for the first quarter of last year, had only a modest impact on overall revenue results. The average US Dollar/Euro exchange rate for the 2013 first quarter was 1.3207 versus 1.3108 for the prior year period.
Net income attributable to common shareholders for the 2013 first quarter was
Adjusting for the impact of this tax benefit and the W.E.T. acquisition transaction expenses,
Further non-cash purchase accounting impacts associated with the W.E.T. acquisition are detailed in the Acquisition Transaction Expenses, W.E.T. Purchase Accounting Impacts and Other Effects table accompanying the release.
Gross margin as a percentage of revenue for this year's first quarter increased to 26.4 percent, up from 25.1 percent for the first quarter of 2012. This increase was primarily the result of a favorable change in product mix and greater coverage of fixed costs at higher volume levels.
Adjusted EBITDA for the 2013 first quarter was
Revaluation of Derivatives
For the 2013 first quarter, the Company recorded gains related to the revaluation of derivative financial instruments of
Research and Development, Selling, General and Administrative Expenses
Net research and development expenses for this year's first quarter were up
Selling, general and administrative (SG&A) expenses for the first quarter of 2013 increased
The Company's balance sheet as of
Guidance
Barring unforeseen economic turbulence, including worsening of the European market or unfavorable fluctuations of the Euro exchange rate, 2013 revenue growth remains strong.
Conference Call
As previously announced,
About
Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Company's actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, additional financing, if necessary, may not be available, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to
TABLES FOLLOW
|
GENTHERM INCORPORATED |
||
|
Three Months Ended |
||
|
March 31, |
||
|
2013 |
2012 |
|
|
Product revenues |
$ 148,090 |
$ 129,526 |
|
Cost of sales |
109,039 |
97,022 |
|
Gross margin |
39,051 |
32,504 |
|
Operating expenses: |
||
|
Net research and development expenses |
11,841 |
10,081 |
|
Acquisition transaction expenses |
1,163 |
— |
|
Selling, general and administrative |
16,256 |
13,973 |
|
Total operating expenses |
29,260 |
24,054 |
|
Operating income |
9,791 |
8,450 |
|
Interest expense |
(981) |
(1,136) |
|
Revaluation of derivatives |
346 |
1,360 |
|
Foreign currency gain (loss) |
987 |
(511) |
|
Income from equity investment |
225 |
— |
|
Other income |
336 |
79 |
|
Earnings before income tax |
10,704 |
8,242 |
|
Income tax expense |
795 |
2,145 |
|
Net income |
9,909 |
6,097 |
|
Gain attributable to non-controlling interest |
(1,258) |
(1,387) |
|
Net income attributable to Gentherm, Inc |
8,651 |
4,710 |
|
Convertible preferred stock dividends |
(923) |
(2,165) |
|
Net income attributable to common shareholders |
$ 7,728 |
$ 2,545 |
|
Basic earnings per share |
$ 0.24 |
$ 0.10 |
|
Diluted earnings per share |
$ 0.24 |
$ 0.10 |
|
Weighted average number of shares – basic |
31,607 |
24,461 |
|
Weighted average number of shares – diluted |
32,084 |
25,151 |
|
GENTHERM INCORPORATED
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME |
||
|
Three Months Ended March 31, |
||
|
2013 |
2012 |
|
|
Net income |
$ 9,909 |
$ 6,097 |
|
Add Back: |
||
|
Income tax expense |
795 |
2,145 |
|
Interest expense |
981 |
1,136 |
|
Depreciation and amortization |
7,679 |
7,264 |
|
Adjustments: |
||
|
Acquisition transaction expense |
1,163 |
— |
|
Unrealized currency (gain) loss |
(913) |
1,524 |
|
Unrealized revaluation of derivatives |
(1,502) |
(2,666) |
|
Adjusted EBITDA |
$ 18,112 |
$ 15,500 |
Use of Non-GAAP Financial Measures
In evaluating its business,
The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP.
|
GENTHERM INCORPORATED |
||||||
|
ACQUISITION TRANSACTION EXPENSES, W.E.T. PURCHASE ACCOUNTING IMPACTS AND OTHER EFFECTS |
||||||
|
(In thousands, except per share data) |
||||||
|
Three Months Ended March 31, |
Future Periods (estimated) |
|||||
|
2013 |
2012 |
2013 |
2014 |
2015 |
Thereafter |
|
|
Transaction related current expenses |
||||||
|
Acquisition transaction expenses |
$ 1,163 |
$ – |
$ 1,163 |
$ – |
$ – |
$ – |
|
Non-cash purchase accounting impacts |
||||||
|
Customer relationships amortization |
$ 1,981 |
$ 1,966 |
$ 7,690 |
$ 7,690 |
$ 7,690 |
$ 39,663 |
|
Technology amortization |
831 |
824 |
3,225 |
3,225 |
3,225 |
6,070 |
|
Product development costs amortization |
548 |
532 |
2,129 |
2,129 |
1,206 |
49 |
|
$ 3,360 |
$ 3,322 |
$ 13,044 |
$ 13,044 |
$ 12,121 |
$ 45,782 |
|
|
Tax effect |
(1,230) |
(769) |
(3,473) |
(3,021) |
(2,807) |
(10,603) |
|
Net income effect |
3,293 |
2,553 |
10,734 |
10,023 |
9,314 |
35,179 |
|
Non-controlling interest effect |
(336) |
(605) |
(394) |
(60) |
(56) |
(211) |
|
Net income available to shareholders effect |
$ 2,957 |
$ 1,948 |
$ 10,340 |
$ 9,963 |
$ 9,258 |
$ 34,968 |
|
Earnings (loss) per share - difference |
||||||
|
Basic |
$ 0.09 |
$ 0.08 |
||||
|
Diluted |
$ 0.09 |
$ 0.08 |
||||
|
Series C Preferred Stock dividend |
$ 923 |
$ 2,165 |
$ 1,622 |
$ – |
$ – |
$ – |
|
Earnings (loss) per share - difference |
||||||
|
Basic |
$ 0.03 |
$ 0.09 |
||||
|
Diluted |
$ 0.03 |
$ 0.09 |
||||
|
GENTHERM INCORPORATED |
||
|
March 31, |
December 31, |
|
|
(unaudited) |
||
|
ASSETS |
||
|
Current Assets: |
||
|
Cash & cash equivalents |
$ 47,977 |
$ 58,152 |
|
Accounts receivable, less allowance of $2,908 and $2,474, respectively |
107,962 |
102,261 |
|
Inventory: |
||
|
Raw Materials |
26,802 |
28,279 |
|
Work in process |
2,924 |
2,461 |
|
Finished goods |
22,512 |
23,016 |
|
Inventory, net |
52,238 |
53,756 |
|
Derivative financial instruments |
148 |
160 |
|
Deferred income tax assets |
13,718 |
15,006 |
|
Prepaid expenses and other assets |
13,663 |
12,809 |
|
Total current assets |
235,706 |
242,144 |
|
Property and equipment, net |
56,900 |
55,010 |
|
Goodwill |
24,004 |
24,729 |
|
Other intangible assets |
89,279 |
95,870 |
|
Deferred financing costs |
1,616 |
1,880 |
|
Deferred income tax assets |
6,956 |
5,361 |
|
Derivative financial instruments |
2,865 |
4,141 |
|
Other non-current assets |
9,866 |
10,062 |
|
Total assets |
$ 427,192 |
$ 439,197 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
||
|
Current Liabilities: |
||
|
Accounts payable |
$ 42,961 |
$ 42,508 |
|
Accrued liabilities |
53,762 |
54,157 |
|
Current maturities of long-term debt |
22,509 |
17,218 |
|
Derivative financial instruments |
3,073 |
3,326 |
|
Total current liabilities |
122,305 |
117,209 |
|
Pension benefit obligation |
4,862 |
5,009 |
|
Other liabilities |
4,146 |
4,540 |
|
Long-term debt, less current maturities |
69,314 |
39,734 |
|
Derivative financial instruments |
10,610 |
13,245 |
|
Deferred income tax liabilities |
22,180 |
21,828 |
|
Total liabilities |
233,417 |
201,565 |
|
Series C Convertible Preferred Stock |
13,527 |
22,469 |
|
Shareholders' equity: |
||
|
Common Stock: |
||
|
No par value; 55,000,000 shares authorized, 33,425,765 and 29,818,225 issued and outstanding at March 31, 2013 and December 31, 2012, respectively |
212,867 |
166,309 |
|
Paid-in capital |
(7,166) |
24,120 |
|
Accumulated other comprehensive loss |
(18,463) |
(11,231) |
|
Accumulated deficit |
(9,655) |
(17,383) |
|
Total Gentherm Incorporated shareholders' equity |
177,583 |
161,815 |
|
Non-controlling interest |
2,665 |
53,348 |
|
Total shareholders' equity |
180,248 |
215,163 |
|
Total liabilities and shareholders' equity |
$ 427,192 |
$ 439,197 |
|
GENTHERM INCORPORATED |
||
|
Three Months Ended March 31, |
||
|
2013 |
2012 |
|
|
Operating Activities: |
||
|
Net income |
$ 9,909 |
$ 6,097 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
||
|
Depreciation and amortization |
7,934 |
7,521 |
|
Deferred tax provision |
(740) |
821 |
|
Stock compensation |
491 |
292 |
|
Defined benefit plan expense |
(53) |
(105) |
|
Provision of doubtful accounts |
434 |
— |
|
Gain on revaluation of financial derivatives |
(1,244) |
(2,471) |
|
Loss (gain) on equity investment |
(176) |
198 |
|
Loss (gain) on sale of property, plant and equipment |
3 |
(8) |
|
Excess tax benefit from equity awards |
— |
(459) |
|
Changes in operating assets and liabilities: |
||
|
Accounts receivable |
(7,765) |
(5,581) |
|
Inventory |
427 |
(2,498) |
|
Prepaid expenses and other assets |
(1,511) |
(1,659) |
|
Accounts payable |
(160) |
581 |
|
Accrued liabilities |
2,490 |
3,737 |
|
Net cash provided by operating activities |
10,039 |
6,466 |
|
Investing Activities: |
||
|
Proceeds from the sale of property, plant and equipment |
1 |
14 |
|
Purchase of property and equipment |
(6,116) |
(3,029) |
|
Loan to equity investment |
— |
(350) |
|
Patent costs |
— |
(14) |
|
Net cash used in investing activities |
(6,115) |
(3,379) |
|
Financing Activities: |
||
|
Borrowing of debt |
40,441 |
41 |
|
Repayments of debt |
(5,182) |
(3,613) |
|
Distributions paid to non-controlling interests |
— |
(173) |
|
Proceeds from public offering of common stock |
— |
75,547 |
|
Excess tax benefit from equity awards |
— |
459 |
|
Purchase of non-controlling interest |
(40,302) |
— |
|
Cash paid to Series C Preferred Stock Holders |
(8,268) |
(55) |
|
Proceeds from the exercise of Common Stock options |
1,487 |
271 |
|
Net cash provided by (used in) financing activities |
(11,824) |
72,477 |
|
Foreign currency effect |
(2,275) |
1,198 |
|
Net increase (decrease) in cash and cash equivalents |
(10,175) |
76,762 |
|
Cash and cash equivalents at beginning of period |
58,152 |
23,839 |
|
Cash and cash equivalents at end of period |
$ 47,977 |
$ 100,601 |
|
Contact: |
Allen & Caron Inc |
|
Jill Bertotti (investors) |
|
|
Len Hall (media) |
|
|
(949) 474-4300 |
SOURCE